VRAX VIRAX BIOLABS GROUP LIMITED

3,358

$0.33

$0.005

(1.54%)

Today

Watchers	3,358
52-Wk Low	$0.302
52-Wk High	$3.16

Market Cap	$5.05M
Volume (M)	111,263.00
52-Wk High	$3.16
52-Wk Low	$0.302

Fundamentals

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts WebinarPR Newswire • 21 days ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only...

Share to Feed

Virax Biolabs names Dr. Nigel McCracken as COOThe Fly • about 1 month ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth MomentumPR Newswire • about 1 month ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth...

Virax Biolabs Group Limited (NASDAQ:VRAX) Sees Significant Drop in Short InterestZolmax • about 1 month ago

Virax Biolabs Group Limited (NASDAQ:VRAX Get Free Report) saw a significant decrease in short interest in August. As of August 15th, there was short interest totalling 4,900 shares, a decrease of 80.3% from the July 31st total of 24,900 shares. Currently, 0.1% of the shares of the stock are sold ...

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 BidPR Newswire • 2 months ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid PR Newswire LONDON, Aug. 3, 2023 LONDON, Aug. 3, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ('Virax' or the...

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory FacilitiesPR Newswire • 3 months ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities PR Newswire LONDON and DUBAI, UAE, July 18, 2023 LONDON andDUBAI, UAE, July 18, 2023...

Short Interest in Virax Biolabs Group Limited (NASDAQ:VRAX) Grows By 42.2%Zolmax • 3 months ago

Virax Biolabs Group Limited (NASDAQ:VRAX Free Report) was the target of a significant increase in short interest in June. As of June 15th, there was short interest totalling 286,700 shares, an increase of 42.2% from the May 31st total of 201,600 shares. Based on an average trading volume of 592,100 ...

Virax Biolabs' CEO James Foster Issues Letter to ShareholdersPR Newswire • 4 months ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders Virax Biolabs' CEO James Foster Issues Letter to Shareholders PR Newswire LONDON and DUBAI, UAE, June 14, 2023 LONDON andDUBAI, UAE, June 14, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ('Virax' or the 'Company&quot...

Virax Biolabs Group (NASDAQ:VRAX) & Aspira Women's Health (NASDAQ:AWH) Head-To-Head AnalysisZolmax • 4 months ago

Virax Biolabs Group (NASDAQ:VRAX Get Rating) and Aspira Womens Health (NASDAQ:AWH Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, ...

Head-To-Head Comparison: Virax Biolabs Group (NASDAQ:VRAX) & Achieve Life Sciences (NASDAQ:ACHV)Ticker Report • 5 months ago

Virax Biolabs Group (NASDAQ:VRAX Get Rating) and Achieve Life Sciences (NASDAQ:ACHV Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, ...